Quick Update for MORN Investors

Today we're going to take a closer look at large-cap Finance company Morningstar, whose shares are currently trading at $248.44. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

Morningstar's P/B and P/E Ratios Are Higher Than Average:

Morningstar, Inc. provides independent investment insights in the United States, Canada, Asia, Australia, Europe, the United Kingdom, and internationally. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Morningstar has a trailing 12 month P/E ratio of 460.1 and a P/B ratio of 8.58.

Morningstar's PEG ratio is 3.6, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Shareholders Are Confronted With a Declining EPS Growth Trend:

2018-03-01 2019-03-01 2020-03-02 2021-02-26 2022-02-25 2023-02-24
Revenue (MM) $912 $1,020 $1,179 $1,390 $1,699 $1,871
Interest Income (MM) -$4 -$2 -$9 -$10 -$9 -$28
Operating Margins 19% 21% 16% 15% 15% 9%
Net Margins 15.0% 18.0% 13.0% 16.0% 11.0% 4.0%
Net Income (MM) $137 $183 $152 $224 $193 $70
Depreciation & Amort. (MM) -$91 -$97 -$118 -$140 -$151 -$167
Earnings Per Share $3.18 $4.26 $3.52 $5.18 $4.45 $1.64
EPS Growth n/a 33.96% -17.37% 47.16% -14.09% -63.15%
Diluted Shares (MM) 43 43 43 43 43 43
Free Cash Flow (MM) $317 $380 $414 $461 $552 $427
Capital Expenditures (MM) -$67 -$66 -$80 -$77 -$102 -$130
Net Current Assets (MM) -$71 $82 -$684 -$695 -$559 -$1,457
Long Term Debt (MM) $180 $70 $502 $449 $359 $1,078
Net Debt / EBITDA -0.66 -1.04 0.47 -0.04 -0.46 2.08

Morningstar has weak revenue growth and a flat capital expenditure trend, irregular cash flows, and significant leverage. We also note that the company has average operating margins with a negative growth trend working in its favor. However, the firm has declining EPS growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS